NEW YORK (GenomeWeb News) – French high-content screening shop Cytoo said today that it has raised $4.7 million in a second funding round.

Cytoo, based in Grenoble, said that it will use the proceeds to grow its business internationally, and to expand its team and R&D efforts around its high-content cell-based screening tools for the life science research market.

New investor Auriga Partners led the financing, while existing investor Jacques Lewiner, the company's co-founder and supervisory board president, also participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.